GL1X · GenesisL1 explorer

Research workbench

Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain

Analyse Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5V8P
Type
protein
Length
790 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
P10845
Ligands
90G, ZN
Pockets
6 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein38834% helix, 18% strandP10845
BBotulinum neurotoxin type a (EC 3.4.24.69)protein40233% helix, 18% strandP10845

Ligands and binding sites

  • 90G · N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanylacetamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19810.780.8064empty
22830.650.813490G
32600.570.783490G, ZN
42420.560.7831empty
52090.530.7832empty

Interfaces

1 interface between chains.

  • A–B · 1785 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 5V8P · Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.